GR72992B - - Google Patents
Info
- Publication number
- GR72992B GR72992B GR63938A GR810163938A GR72992B GR 72992 B GR72992 B GR 72992B GR 63938 A GR63938 A GR 63938A GR 810163938 A GR810163938 A GR 810163938A GR 72992 B GR72992 B GR 72992B
- Authority
- GR
- Greece
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/54—Nitrogen and either oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP755880A JPS56104876A (en) | 1980-01-24 | 1980-01-24 | Thiazolidine derivative |
JP10471880A JPS5728075A (en) | 1980-07-29 | 1980-07-29 | Thiazolidine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
GR72992B true GR72992B (el) | 1984-01-23 |
Family
ID=26341877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR63938A GR72992B (el) | 1980-01-24 | 1981-01-22 |
Country Status (9)
Country | Link |
---|---|
US (1) | US4387101A (el) |
EP (1) | EP0033617A3 (el) |
AR (1) | AR228144A1 (el) |
AU (1) | AU6610081A (el) |
DK (1) | DK30781A (el) |
ES (1) | ES8301951A1 (el) |
GR (1) | GR72992B (el) |
PH (1) | PH15937A (el) |
PT (1) | PT72390B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58177983A (ja) * | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
EP0117035B1 (en) * | 1983-01-17 | 1989-08-16 | Pfizer Inc. | Aldose reductase inhibiting 5-(2-alkoxyphenyl)thiazolidinediones |
US4617312A (en) * | 1983-01-17 | 1986-10-14 | Pfizer Inc. | Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones |
JPS6143114A (ja) * | 1984-08-03 | 1986-03-01 | Takeda Chem Ind Ltd | 虹彩・毛様体疾患治療用眼局所投与剤 |
US5356917A (en) * | 1985-08-09 | 1994-10-18 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
US5691367A (en) * | 1985-08-09 | 1997-11-25 | Eli Lilly And Company | Aryl-substituted rhodanine derivatives |
US5216002A (en) * | 1989-12-21 | 1993-06-01 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
US5158966A (en) * | 1991-02-22 | 1992-10-27 | The University Of Colorado Foundation, Inc. | Method of treating type i diabetes |
RU2098094C1 (ru) * | 1991-03-27 | 1997-12-10 | Сендзю Фармасьютикал Ко., Лтд. | Способ приготовления водной суспензии и водный глазной препарат |
CZ181493A3 (en) * | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
US6251928B1 (en) | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
KR20010099623A (ko) * | 1998-08-21 | 2001-11-09 | 비로파마 인코포레이티드 | 바이러스 감염 및 관련 질병을 치료 또는 예방하는화합물, 조성물 및 방법 |
ES2265952T3 (es) * | 1999-06-18 | 2007-03-01 | MERCK & CO., INC. | Derivados de ariltiazolidindiona y ariloxazolidindiona. |
AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
US6531461B1 (en) | 2001-06-04 | 2003-03-11 | Louis Obyo Obyo Nelson | Medicament for the treatment of diabetes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2255903A (en) * | 1938-07-25 | 1941-09-16 | Lilly Co Eli | 5,5-disubstituted-2,4-thiazolidiones, and process of making them |
FR909629A (fr) * | 1944-05-25 | 1946-05-14 | Ste Ind Chim Bale | Procédé pour lutter contre les organismes nuisibles |
US2678318A (en) * | 1949-08-19 | 1954-05-11 | Beecham Res Lab | Preparation of alpha-amino acids |
FR1222411A (fr) * | 1955-05-19 | 1960-06-09 | Searle & Co | Procédé de préparation de 2,4-diaminothiazols contenant un radical aryle halogéné |
IT649883A (el) * | 1960-05-24 | |||
US3825553A (en) * | 1970-05-05 | 1974-07-23 | Rorer Inc William H | Certain 5-arylthiazolidines |
US3864384A (en) * | 1970-05-05 | 1975-02-04 | Rorer Inc William H | Substituted phenylacetic acid compounds |
YU37171B (en) * | 1975-12-05 | 1984-08-31 | Krka Novo Mesto | Process for preparing 7-(d-2-amino-2-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid |
DE2655369A1 (de) * | 1976-12-03 | 1978-06-08 | Schering Ag | 5-(subst. phenyl)-oxazolidinone und deren schwefelanaloga sowie verfahren zu deren herstellung |
EP0002978B1 (fr) * | 1977-12-29 | 1982-10-06 | Synthelabo | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique |
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
-
1981
- 1981-01-09 AU AU66100/81A patent/AU6610081A/en not_active Abandoned
- 1981-01-21 PH PH25117A patent/PH15937A/en unknown
- 1981-01-21 US US06/227,786 patent/US4387101A/en not_active Expired - Lifetime
- 1981-01-22 AR AR284033A patent/AR228144A1/es active
- 1981-01-22 GR GR63938A patent/GR72992B/el unknown
- 1981-01-23 PT PT72390A patent/PT72390B/pt unknown
- 1981-01-23 DK DK30781A patent/DK30781A/da unknown
- 1981-01-23 EP EP81300308A patent/EP0033617A3/en not_active Withdrawn
- 1981-12-31 ES ES508490A patent/ES8301951A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
EP0033617A2 (en) | 1981-08-12 |
US4387101A (en) | 1983-06-07 |
AR228144A1 (es) | 1983-01-31 |
PT72390A (en) | 1981-02-01 |
PH15937A (en) | 1983-04-29 |
ES508490A0 (es) | 1982-12-16 |
PT72390B (en) | 1981-12-21 |
AU6610081A (en) | 1981-07-30 |
EP0033617A3 (en) | 1981-08-26 |
DK30781A (da) | 1981-07-25 |
ES8301951A1 (es) | 1982-12-16 |